Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice

Table 1 Background characteristics of survey respondents

Parameter		n (%)
	University hospital	256 (78.8)
Practice setting	Regional/district hospital	33 (10.1)
	Outpatient clinic	36 (11.1)
	Less than 25%	183 (55.3)
IBD in clinic	25% or more (IBD expert)	148 (46.7)
Years of practice, median (IQR, range)		10.5 (5-20, 0.5-60)
Country of practice	Australia	31 (9.1)
	Brazil	22 (6.5)
	Canada	40 (11.8)
	China	38 (11.2)
	France	9 (2.6)
	Greece	46 (13.5)
	Israel	33 (9.7)
	Italy	19 (5.8)
	South Korea	20 (5.9)
	Serbia	10 (2.9)
	United Kingdom	19 (5.8)
	United States	53 (15.6)